New Covid variant 'evades antibodies' and is 'potentially emerging' says World Health Organisation.
"UK Health Security Agency has restated Covid advice including 'wearing masks' if you get it"
Source: https://archive.md/bIVhx
Doctors tested a common drug on COVID. The results are stunning.
A new international study led by the Australian National University (ANU) and King’s College London found inhaled heparin, a cheap and widely available drug, halved the need for ventilation and lowered death risk in nearly 500 hospitalised COVID patients across 6 nations.
ANU's Professor van Haren, said: "Inhaled heparin is anti-viral, anti-inflammatory and anti-coagulant. There's no other drug that has that unique combination."
Source: https://archive.md/Uifo9
Study: https://www.thelancet.com/journals/eclinm/article/PIIS2589-5370(25)00271-8/fulltext
By thetranscendedman @atranscendedman
Barcelona researchers followed 192,000 people and found long COVID was 3–10 times more common in those with three or more infections than in those with just one.
Thrombotic events in people over 60 have doubled since 2020.
Source:
Sharp rise in memory and thinking problems among 🇺🇸 U.S. adults, study finds.
"A growing number of U.S. adults—particularly those under 40—are reporting serious challenges with memory, concentration and decision-making, according to a new study published in Neurology"
Source: https://archive.md/kiCqm
Study: https://www.neurology.org/doi/10.1212/WNL.0000000000214226
🇦🇺 AUSTRALIA Weekly COVID Update: 26 September 2025
ACT saw a big jump (+30.5%)
QLD down (–27.3%, 43 in hospital); WA down (–16.6%, 42/day in hospital); NSW down (–14.9%) and SA down (–5.2%, 6 deaths reported)
Aged care down (–39.4%) and 2 deaths reported
VIC & TAS report next: Oct 3
🇦🇺 Australia: "Many products used to protect healthcare workers during COVID weren’t up to scratch"
The TGA has tightened rules for face masks and respirators on the Australian Register of Therapeutic Goods (ARTG) after a review found many products added early in the pandemic didn’t meet safety or quality standards.
Source: https://archive.md/2j4O6
Outpatient antibiotic use in COVID patients linked to 'downstream' antibiotic resistance.
A study of 50,000+ Canadian seniors diagnosed with COVID-19 found that antibiotic use within 7 days of diagnosis was linked to antibiotic-resistant organisms, researchers reported today in NEJM Evidence.
Source:
Researchers in Spain have developed a novel, next-generation, intranasally administered vaccine against the SARS-CoV-2.
"While a single dose provides 60% protection in mice, the use of double intranasal immunization achieves 100% protection against SARS-CoV-2 infection. Furthermore, the undetectable levels of virus in nasal and lung samples indicate that the immunization is sterilizing
Source:
